Dark | Light
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

[$onco](/topic/$onco)

### Sentiment: XX%
![Sentiment Line Chart](https://lunarcrush.com/gi/w:600/t:$onco/c:line/m:sentiment.svg)  
[Sentiment 24-Hour Chart Data](/topic/$onco/time-series/sentiment.tsv)  
**Current Value**: XX%  
**Daily Average**: XX%  
**1 Month**: XX% -X%  
**6 Months**: XX% -X%  
**1 Year**: XX% -XX%  
**1-Year High**: XXX% on 2024-07-27  
**1-Year Low**: XX% on 2024-09-20  

**Most Supportive Themes**
- **Positive Mentions and Recommendations:** (30%) Many posts highlight $ONCO as a stock to watch, with some users recommending it for potential gains and others mentioning it in the context of successful portfolios.
- **Merger Announcement:** (25%) The merger announcement with Ocuvex Therapeutics is a key development, with some users speculating on its potential impact and others noting the low float.
  
**Most Critical Themes**
- **Price Decline and Negative Performance:** (15%)  Several posts mention $ONCO experiencing significant losses, with some noting it among the top losers in the market.
  
Network engagement breakdown:  
| Network | Positive | %   | Neutral | %   | Negative | %   |
| ------- | -------- | -   | ------- | -   | -------- | -   |
| X       | XXXXXX   | XX% | XXXXXX  | XX% | XXXXXX   | XX% |
|         |          |     |         |     |          |     |
| Total   | XXXXXX   | XX% | XXXXXX  | XX% | XXXXXX   | XX% |

[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

$onco

Sentiment: XX%

Sentiment Line Chart
Sentiment 24-Hour Chart Data
Current Value: XX%
Daily Average: XX%
1 Month: XX% -X%
6 Months: XX% -X%
1 Year: XX% -XX%
1-Year High: XXX% on 2024-07-27
1-Year Low: XX% on 2024-09-20

Most Supportive Themes

  • Positive Mentions and Recommendations: (30%) Many posts highlight $ONCO as a stock to watch, with some users recommending it for potential gains and others mentioning it in the context of successful portfolios.
  • Merger Announcement: (25%) The merger announcement with Ocuvex Therapeutics is a key development, with some users speculating on its potential impact and others noting the low float.

Most Critical Themes

  • Price Decline and Negative Performance: (15%) Several posts mention $ONCO experiencing significant losses, with some noting it among the top losers in the market.

Network engagement breakdown:

Network Positive % Neutral % Negative %
X XXXXXX XX% XXXXXX XX% XXXXXX XX%
Total XXXXXX XX% XXXXXX XX% XXXXXX XX%
$onco Sentiment
/topic/$onco/sentiment